Healthcare
•3734 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3734)
| Company | Market Cap | Price |
|---|---|---|
|
ZCMD
Zhongchao Inc.
ZCMD provides healthcare information services and patient management systems to healthcare professionals and institutions, fitting Healthcare Services & Facilities.
|
$4.89M |
$1.77
+14.94%
|
|
PULM
Pulmatrix, Inc.
Pulmatrix's core offering is the iSPERSE dry powder drug delivery platform, a direct product category.
|
$4.60M |
$1.24
-1.20%
|
|
CLGN
CollPlant Biotechnologies Ltd.
rhCollagen is a recombinant protein, and CollPlant's core product is plant-derived recombinant human collagen used in implants, fillers, and bioinks.
|
$4.56M |
$0.36
+2.19%
|
|
LCTC
Lifeloc Technologies, Inc.
Lifeloc Technologies manufactures breath alcohol testing devices, which are diagnostic instruments used for disease detection and monitoring.
|
$4.52M |
$1.84
|
|
YMAT
J-Star Holding Co., Ltd. Ordinary Shares
Produces medical device components used in healthcare applications, reflecting a direct product line.
|
$4.51M |
$0.31
+9.39%
|
|
BIXT
Bioxytran, Inc.
MDX Viewer is an FDA-approved diagnostic device that measures tissue oxygenation and provides real-time metabolic insights; a direct product/service Bioxytran provides.
|
$4.42M |
$0.04
|
|
XAIR
Beyond Air, Inc.
LungFit is a medical device platform that generates nitric oxide and is sold/distributed to hospitals.
|
$4.36M |
$0.53
+19.16%
|
|
POAI
Predictive Oncology Inc.
Biotech - Oncology focus via proprietary biobank, wet-lab validation, and AI-enabled oncology drug discovery.
|
$4.32M |
$5.94
-0.17%
|
|
ALZN
Alzamend Neuro, Inc.
Company's pipeline includes Alzheimer's disease therapeutics (ALZN002) and a focused strategy on Alzheimer's treatment.
|
$4.26M |
$1.11
+11.00%
|
|
TTNP
Titan Pharmaceuticals, Inc.
Titan's core ProNeura technology is a long-acting drug delivery platform used for subdermal implants.
|
$4.21M |
$4.61
|
|
CYCN
Cyclerion Therapeutics, Inc.
Cyclerion is centered on neuropsychiatric drug development, specifically an individualized therapy for Treatment Resistant Depression (TRD).
|
$4.14M |
$1.24
-0.40%
|
|
BUDZ
WEED, Inc.
Sangre AgroTech represents plant genomic research services, akin to contract research and development.
|
$4.08M |
$0.03
|
|
SONN
Sonnet BioTherapeutics Holdings, Inc.
Sonnet's core pipeline is oncology-focused immunotherapies (e.g., SON-1010 IL-12) leveraging the FHAB platform.
|
$3.99M |
$1.28
+1.98%
|
|
HCWC
Healthy Choice Wellness Corp.
HCWC runs licensed wellness centers offering services such as IV nutrient drips, i.e., Healthcare Services & Facilities.
|
$3.98M |
$0.30
-43.17%
|
|
BGLC
BioNexus Gene Lab Corp.
VitaGuard MRD is a tumor-naïve liquid biopsy platform used in BGLC's MRNA Scientific diagnostics, defining a liquid biopsy product category.
|
$3.95M |
$2.20
+1.02%
|
|
FBLG
FibroBiologics, Inc. Common Stock
Core business is fibroblast-based cell therapies (CYWC628, CYMS101, CybroCell) in regenerative medicine; directly matches Biotech - Cell Therapy.
|
$3.94M |
$1.55
+1.97%
|
|
SNOA
Sonoma Pharmaceuticals, Inc.
Company offers HOCl-based wound care products that function as wound care solutions/devices.
|
$3.91M |
$2.30
+4.07%
|
|
OGEN
Oragenics, Inc.
ONP-002 uses a proprietary intranasal drug-delivery platform (powder formulation + breath-propelled device).
|
$3.77M |
$0.95
+2.56%
|
|
CLDI
Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics directly develops cancer therapies (oncolytic virus platforms) targeting oncology indications.
|
$3.77M |
$0.77
+4.55%
|
|
LADX
LadRx Corporation
LadRx is a biotechnology company focused on oncology drug development.
|
$3.70M |
$0.11
|
|
GTCH
GBT Technologies Inc.
GTCH's qTerm device and biometrics relate to medical devices/biometrics category.
|
$3.70M |
$0.00
|
|
CDIO
Cardio Diagnostics Holdings, Inc.
Provides laboratory testing services and advisory support for diagnostics.
|
$3.67M |
$2.05
+4.59%
|
|
ENTO
Entero Therapeutics, Inc.
Adrulipase is a recombinant lipase enzyme produced as a therapeutic for exocrine pancreatic insufficiency, fitting Recombinant Proteins & Enzymes.
|
$3.65M |
$2.96
+22.31%
|
|
ADMT
ADM Tronics Unlimited, Inc.
Company designs and manufactures medical devices and biometric sensing technologies including diagnostics and therapeutics.
|
$3.64M |
$0.08
|
|
BZYR
Burzynski Research Institute, Inc.
Company focuses on oncology therapeutics in biotech R&D.
|
$3.29M |
$0.02
|
|
SILO
Silo Pharma, Inc.
Drug Delivery Platforms directly describes Silo's intranasal and implantable drug delivery technologies (SPC-15, SPC-14, SP-26).
|
$3.28M |
$0.34
-3.64%
|
|
CASI
CASI Pharmaceuticals, Inc.
CID-103 is a monoclonal antibody therapeutic, a core product class for the company.
|
$3.22M |
$0.21
+2.99%
|
|
GOVX
GeoVax Labs, Inc.
GeoVax directly develops and manufactures vaccines using its MVA platform for infectious diseases (Mpox/smallpox and COVID-19 programs).
|
$3.20M |
$3.16
+9.72%
|
|
HIGR
Hi-Great Group Holding Company
KRAS gene license places HIGR in Biotech - Oncology, an oncology-focused biotech asset.
|
$3.18M |
$0.03
|
|
IOBT
IO Biotech, Inc.
IO Biotech's lead candidate is a therapeutic cancer vaccine (off-the-shelf cancer vaccines) and IO102-IO103 is built on a vaccine platform.
|
$3.16M |
$0.05
+2.08%
|
|
VERO
Venus Concept Inc.
Venus Concept produces medical aesthetic devices and robotic systems (Venus platforms, ARTAS iX) and related medical devices.
|
$3.10M |
$2.23
+33.23%
|
|
AMIX
Autonomix Medical, Inc. Common Stock
Core platform is a catheter-based Neuromodulation Device designed to sense and ablate peripheral nerves.
|
$3.10M |
$0.63
+4.38%
|
|
MRAI
Marpai, Inc.
PBMs (Pharmacy Benefit Managers) theme reflecting MarpaiRx's prescription cost management objectives.
|
$2.99M |
$0.29
|
|
PHGE
BiomX Inc.
BiomX leverages a drug delivery platform (BOLT) to rapidly assemble phage cocktails and targeted therapies.
|
$2.81M |
$1.80
-8.38%
|
|
KALA
KALA BIO, Inc.
KPI-012 is a mesenchymal stem cell secretome (MSC-S) therapy, aligning with Biotech - Cell Therapy.
|
$2.67M |
$0.38
-5.27%
|
|
JAGX
Jaguar Health, Inc.
Jaguar Health focuses on crofelemer-based therapies delivered orally, aligning with the Oral Small Molecule Therapeutics category.
|
$2.54M |
$1.18
+3.98%
|
|
AIM
AIM ImmunoTech Inc.
Ampligen is AIM ImmunoTech's flagship oncology/immunotherapy platform and is being developed with cancer indications (pancreatic and ovarian cancer) in combination with checkpoint inhibitors.
|
$2.46M |
$0.91
|
|
VTAK
Catheter Precision, Inc.
VTAK's VIVO System is a cardiology-focused medical device for non-invasive 3D mapping, aligning with Cardiology Devices.
|
$2.43M |
$2.15
-3.15%
|
Showing page 36 of 38 (3734 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
